in terms of areas under the curve , the mean bioavailability of the 40 mg sustained release capsule relative to the reference formulation was 198 % with respect to isdn , and 197 % both with respect to is-2-n and is-5-n .
C0028125
is-2-n
C0064079
is-5-n